Clinical Trials
2 trialsNCT00060112 2013-01-25
Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00301795 2013-01-07
Rituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Terminated